Walmart to replace AstraZeneca on Nasdaq-100 Index on January 20
Walmart will replace British drugmaker AstraZeneca in the Nasdaq-100 Index on January 20, the exchange operator said on Friday. The retail giant said in November it would shift its longtime listing on the New York Stock Exchange to its main rival. Companies typically change listing venues when they see better alignment with an exchange’s investor…